{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-019143","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.534651+00:00","generated_at":"2026-05-16T00:48:03.441227+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Palvella Therapeutics reports preliminary Dec 31, 2025 cash of $55.9M","bullets":["Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2025: $55.9 million.","Amount subject to change upon completion of financial close procedures; not audited by Ernst & Young.","No other financial results provided; full year 2025 results pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-019143","json":"https://secwatch.observer/filing/0001104659-26-019143.json","markdown":"https://secwatch.observer/filing/0001104659-26-019143.md","text":"https://secwatch.observer/filing/0001104659-26-019143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/0001104659-26-019143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926019143/tm267157d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:48:03.441227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}